Avai Bio (AVAI) Receivables (2020 - 2022)

Avai Bio has disclosed Receivables across 3 years of filings, most recently posting $64444.0 for Q4 2022.

• Receivables for Q4 2022 came in at $64444.0, up 7.95% year-over-year; the trailing twelve-month figure through Dec 2022 was $64444.0 (up 7.95% YoY), and the FY2022 annual result was $3765.0, down 94.08% from the prior year.
• Receivables came in at $64444.0 for Q4 2022 at Avai Bio, up from $6644.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $231953.0 in Q2 2021 to a low of $3765.0 in Q1 2022.
• The 3-year median for Receivables is $61363.0 (2021), against an average of $75861.3.
• Across the five-year window, Receivables jumped 147.71% in 2021 and slumped 94.08% in 2022, its largest moves.
• Avai Bio's Receivables stood at $204839.0 in 2020, then slumped by 70.86% to $59696.0 in 2021, then advanced by 7.95% to $64444.0 in 2022.
• The last three Receivables figures came in at $64444.0 (Q4 2022), $6644.0 (Q3 2022), and $13828.0 (Q2 2022), per Business Quant data.